Provided by Tiger Trade Technology Pte. Ltd.

Kymera Therapeutics, Inc.

87.36
-0.0400-0.05%
Volume:359.10K
Turnover:31.44M
Market Cap:6.90B
PE:-24.28
High:89.49
Open:87.16
Low:85.70
Close:87.40
52wk High:103.00
52wk Low:19.45
Shares:78.95M
Float Shares:54.63M
Volume Ratio:0.54
T/O Rate:0.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5975
EPS(LYR):-2.9830
ROE:-32.09%
ROA:-19.21%
PB:7.29
PE(LYR):-29.29

Loading ...

Feb 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2026

Major Issues Report

Form 8-K - Current report
Dec 31, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 10, 2025

Major Issues Report

Form 8-K - Current report
Dec 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 08, 2025

Major Issues Report

Form 8-K - Current report
Nov 04, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2025

Major Issues Report

Form 8-K - Current report
Oct 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities